Selective activation of angiotensin AT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective activation of angiotensin AT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 9, Pages 2219-2231
Publisher
Wiley
Online
2014-12-19
DOI
10.1111/bph.13044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
- (2015) Daniel Villela et al. CLINICAL SCIENCE
- Relative affinity of angiotensin peptides and novel ligands at AT1and AT2receptors
- (2015) Sanja Bosnyak et al. CLINICAL SCIENCE
- Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury
- (2013) Gerry T. M. Wagenaar et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
- (2013) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery and Characterization of Alamandine
- (2013) Roberto Queiroga Lautner et al. CIRCULATION RESEARCH
- Protective arms of the renin-angiotensin-system in neurological disease
- (2013) Colin Sumners et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats
- (2013) Quaisar Ali et al. KIDNEY INTERNATIONAL
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
- (2012) Frances S. de Man et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
- (2012) Pawel Namsolleck et al. NEUROBIOLOGY OF DISEASE
- Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders
- (2012) David C. Budd et al. PHARMACOLOGY & THERAPEUTICS
- ACE2, a promising therapeutic target for pulmonary hypertension
- (2011) Vinayak Shenoy et al. CURRENT OPINION IN PHARMACOLOGY
- Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury
- (2011) Yanfei Qi et al. EXPERIMENTAL PHYSIOLOGY
- Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology
- (2011) YanFei Qi et al. EXPERIMENTAL PHYSIOLOGY
- Mechanisms of disease: pulmonary arterial hypertension
- (2011) Ralph T. Schermuly et al. Nature Reviews Cardiology
- The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension
- (2010) Vinayak Shenoy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-peptide AT2-receptor agonists
- (2010) U Muscha Steckelings et al. CURRENT OPINION IN PHARMACOLOGY
- Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases
- (2010) Anderson J. Ferreira et al. EXPERIMENTAL PHYSIOLOGY
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
- (2010) Franziska Rompe et al. HYPERTENSION
- The Right Ventricle Under Pressure
- (2009) Harm J. Bogaard et al. CHEST
- Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
- (2009) T. Thenappan et al. EUROPEAN RESPIRATORY JOURNAL
- Polymorphism in the Angiotensin II Type 1 Receptor (AGTR1) is Associated With Age at Diagnosis in Pulmonary Arterial Hypertension
- (2009) Wendy K. Chung et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage
- (2009) Paolo Gelosa et al. JOURNAL OF HYPERTENSION
- Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
- (2009) Paul M. Hassoun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin II Type 2 Receptor Stimulation
- (2008) Elena Kaschina et al. CIRCULATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started